Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 7711 AL 7725

Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series assessment using a validated disease-specific scale

Ray DK, Bahgat D, McCartney S, Burchiel KJ.

Stereotact Funct Neurosurg. 2010;88(6):383-9. doi: 10.1159/000319883. Epub 2010 Oct 15.

Beneficial effects of an innovative exercise model on motor and oxidative disorders induced by haloperidol in rats

Teixeira A, Müller LG, Reckziegel P, Boufleur N, Pase CS, Villarinho JG, Fachinetto R, Ferreira J, Rocha JB, Bürger ME.

Neuropharmacology. 2011 Feb-Mar;60(2-3):432-8. doi: 10.1016/j.neuropharm.2010.10.017. Epub 2010 Oct 28.

[Iatrogenic psychiatric-like symptoms recognition]

Demily C, Chouinard VA, Chouinard G.

Encephale. 2010 Oct;36(5):417-24. doi: 10.1016/j.encep.2010.01.003. Epub 2010 Mar 6.

High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit

Haynes WI, Mallet L.

Eur J Neurosci. 2010 Oct;32(7):1118-27. doi: 10.1111/j.1460-9568.2010.07418.x.

An alternative impression technique for individuals with special care needs

Topouzelis N, Kotsiomiti E, Arhakis A.

Spec Care Dentist. 2010 Nov-Dec;30(6):266-70. doi: 10.1111/j.1754-4505.2010.00165.x. Epub 2010 Oct 19.

Diagnostic criteria for the classification of vocal cord dysfunction

Morris MJ, Christopher KL.

Chest. 2010 Nov;138(5):1213-23. doi: 10.1378/chest.09-2944.

Epilepsia partialis continua in children with fulminant subacute sclerosing panencephalitis

Kravljanac R, Jovic N, Djuric M, Nikolic L.

Neurol Sci. 2011 Dec;32(6):1007-12. doi: 10.1007/s10072-010-0442-y. Epub 2010 Oct 30.

Severe akathisia as a side effect of metoclopramide

Van Gool AR, Doorduijn JK, Seynaeve C.

Pharm World Sci. 2010 Dec;32(6):704-6. doi: 10.1007/s11096-010-9444-3. Epub 2010 Oct 30.

Scintigraphic, neuroradiological and clinical comparison in two patients with primary sporadic and two with secondary Fahr's disease

Caranci G, Grillea G, Barbato F, Brunetti A, Tassinari T, Di Ruzza M, Lena F, Gandolfi B, Castellano AE, Bartolo M, Colonnese C, Modugno N, Ruggieri S, Manfredi M.

Neurol Sci. 2011 Apr;32(2):337-41. doi: 10.1007/s10072-010-0444-9. Epub 2010 Nov 6.

Mitochondrial transfer RNA(Phe) mutation associated with a progressive neurodegenerative disorder characterized by psychiatric disturbance, dementia, and akinesia-rigidity

Young TM, Blakely EL, Swalwell H, Carter JE, Kartsounis LD, O'Donovan DG, Turnbull DM, Taylor RW, de Silva RN.

Arch Neurol. 2010 Nov;67(11):1399-402. doi: 10.1001/archneurol.2010.283.

Clozapine versus other atypical antipsychotics for schizophrenia

Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S.

Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD006633. doi: 10.1002/14651858.CD006633.pub2.

Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation

Korchounov A, Meyer MF, Krasnianski M.

J Neural Transm (Vienna). 2010 Dec;117(12):1359-69. doi: 10.1007/s00702-010-0454-z. Epub 2010 Nov 16.

Microbeam radiosurgery using synchrotron-generated submillimetric beams: a new tool for the treatment of brain disorders

Anschel DJ, Bravin A, Romanelli P.

Neurosurg Rev. 2010 Apr;34(2):133-42. doi: 10.1007/s10143-010-0292-3. Epub 2010 Nov 19.

Review and update of involuntary facial movement disorders presenting in the ophthalmological setting

Ross AH, Elston JS, Marion MH, Malhotra R.

Surv Ophthalmol. 2011 Jan-Feb;56(1):54-67. doi: 10.1016/j.survophthal.2010.03.008. Epub 2010 Nov 20.

A treatable cause for a painful movement disorder

Paling D, Irfan M, Jones S, Shaunak S.

Pract Neurol. 2010 Dec;10(6):351-4. doi: 10.1136/jnnp.2010.230490.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias